Dennis M. Lanfear, President & CEO at Coherus BioSciences, Inc. (CHRS), sold 64,796 shares at $19.49 ($1.3M) on 2019-05-30, disclosed to the SEC on 2019-05-31.
Open-market sale of $1.3M CHRS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.49 | 32,398 | $631K | 50.0% |
| 2 | $19.49 | 32,398 | $631K | 50.0% |
| Total | $19.49 avg | 64,796 | $1.3M | 100% |
| Filing → |
| CHRS | SELL | 2019-11-25 | $464K | — | Filing → |
| CHRS | SELL | 2019-11-22 | $14.8M | — | Filing → |
| CHRS | SELL | 2018-05-17 | $682K | — | Filing → |